Cargando…
Circulating Ang-2 mRNA Expression Levels: Looking Ahead to a New Prognostic Factor for NSCLC
Non-small cell lung cancer (NSCLC) is the most common cancer and the leading cause of death from cancer worldwide. Antiangiogenic strategies directed towards tumor stroma are becoming gold standard in NSCLC treatment and researchers have been searching for biomarkers to identify patients for whom th...
Autores principales: | Coelho, Ana L., Araújo, António, Gomes, Mónica, Catarino, Raquel, Marques, Agostinho, Medeiros, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938581/ https://www.ncbi.nlm.nih.gov/pubmed/24587185 http://dx.doi.org/10.1371/journal.pone.0090009 |
Ejemplares similares
-
Correction: Circulating Ang-2 Mrna Expression Levels: Looking ahead to a New Prognostic Factor for NSCLC
Publicado: (2014) -
Circulating DNA: Diagnostic Tool and Predictive Marker for Overall Survival of NSCLC Patients
por: Catarino, Raquel, et al.
Publicado: (2012) -
CSF-1 and Ang-2 serum levels — prognostic and diagnostic partners in non-small cell lung cancer
por: Coelho, Ana Luísa, et al.
Publicado: (2018) -
Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches?
por: Coelho, Ana Luísa, et al.
Publicado: (2016) -
Looking Ahead to the Future...
por: Almeida, Rui M. S.
Publicado: (2018)